Literature DB >> 31529607

Integration of an Addiction Team in a Liver Transplantation Center.

Hélène Donnadieu-Rigole1,2, Laura Jaubert1, José Ursic-Bedoya3, Bertrand Hanslik1, Thibault Mura4,5, Lucie Gamon4, Stéphanie Faure3, Francis Navarro5,6, Pascal Perney5,7, Astrid Herrero5,6, Georges-Philippe Pageaux3,5.   

Abstract

Up to 50% of liver transplantation (LT) recipients with known or clandestine alcohol-use disorder (AUD) before surgery return to alcohol use after LT. However, only severe alcohol relapse, which varies in frequency from 11% to 26% of patients, has an impact on longterm survival and significantly decreases survival rates after 10 years. Therefore, it is crucial to identify patients with the highest risk of severe relapse in order to arrange specific, standardized monitoring by an addiction team before and after LT. The aims of this study were to describe the effects of combined management of AUD on the rate of severe alcohol relapse and to determine the risk factors before LT that predict severe relapse. Patients transplanted between January 2008 and December 2014 who had met with the LT team's addiction specialist were included in the study. Patients who exhibited alcohol-related relapse risk factors received specific addiction follow-up. A total of 235 patients were enrolled in the study. Most of them were men (79%), and the mean age at the time of the LT was 55.7 years. Severe relapse occurred in only 9% of the transplant recipients. Alcohol-related factors of severe relapse were a pretransplant abstinence of 6 months and family, legal, or professional consequences of alcohol consumption, whereas the nonalcohol-related factors were being single and being eligible for a disability pension. In conclusion, the integration of an addiction team in a LT center may be beneficial. The addiction specialist can identify patients at risk of severe relapse in the pretransplantation period and hence arrange for specific follow-up.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 31529607     DOI: 10.1002/lt.25641

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

1.  Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.

Authors:  Gene Y Im; Jessica L Mellinger; Adam Winters; Elizabeth S Aby; Zurabi Lominadze; John Rice; Michael R Lucey; Juan P Arab; Aparna Goel; Loretta L Jophlin; Courtney B Sherman; Richard Parker; Po-Hung Chen; Deepika Devuni; Sandeep Sidhu; Winston Dunn; Gyongyi Szabo; Ashwani K Singal; Vijay H Shah
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-16       Impact factor: 11.382

2.  Establishing a blueprint for successful liver transplantation for alcohol-related cirrhosis: the importance of a multidisciplinary team.

Authors:  José Ursic-Bedoya; Hélène Donnadieu-Rigole
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

3.  Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates.

Authors:  Ahsan Syed; Matthew D Sadler; Meredith A Borman; Kelly W Burak; Stephen E Congly
Journal:  Can Liver J       Date:  2020-11-17

4.  Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis.

Authors:  Anton L V Avanceña; Nicholas Miller; Sarah E Uttal; David W Hutton; Jessica L Mellinger
Journal:  J Hepatol       Date:  2020-12-14       Impact factor: 30.083

Review 5.  Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation.

Authors:  Juan Pablo Arab; Manhal Izzy; Lorenzo Leggio; Ramon Bataller; Vijay H Shah
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-01       Impact factor: 73.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.